Xcout IntelGlaukos Corporation competitors & alternatives
The 12 closest competitors and alternatives to Glaukos Corporation among medical devices companies — ranked by similarity to what Glaukos Corporation actually does, not by market-cap band.
Subscribe to see Glaukos Corporation’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Glaukos Corporation
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Glaukos Corporation at a glance
Glaukos Corporation is a medical devices company headquartered in Aliso Viejo, United States. It is publicly listed (GKOS) with a market capitalisation of $9.8B. Xcout tracks 18 named people at Glaukos Corporation, including Thomas William Burns (Chairman & Chief Executive Officer).
Glaukos Corporation leadership
- Thomas William BurnsChairman & Chief Executive Officer
- Joseph E. GilliamPresident & Chief Operating Officer
- Alex R. ThurmanSenior Vice President & Chief Financial Officer
- Tomas NavratilChief Development Officer
- L. Jay Katz FACSChief Medical Officer
- Michele AllegrettoSenior Vice President of Human Resources
12 more named people on record for Glaukos Corporation, with roles, board committees and tenure — see the full roster →
Top 12 Glaukos Corporation competitors
Ranked by semantic similarity — how close each company is to Glaukos Corporation by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Device
Avedro, Inc. is a company that developed novel therapies for the treatment of corneal disorders, glaucoma, and retinal diseases before being acquired by Glaukos Corporation.
Similar medical devices company
Eximore is a biopharmaceutical platform company headquartered in Israel that is focused on designing innovative solutions for the ophthalmological community. The company develops revolutionary integrated therapeutic delivery systems to address complex eye care needs.
Similar medical devices company
Eye Bright Medical Technology Co., Ltd., established in 2010 in Beijing, China, specializes in crafting a diverse array of ophthalmic medical solutions. The company's extensive product line is geared towards addressing various ocular conditions and visual impairments, encompassing surgical implants, specialized instruments, and diagnostic equipment, as well as optometric lenses and pharmaceutical eye drops. These innovations are developed to provide treatment for a range of eye diseases, notably cataracts, glaucoma, and refractive errors, among other ophthalmic issues.
Similar medical devices company
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially reduce systemic drug exposure and mitigate associated side effects. HEPZATO's clinical evaluation is advancing through the FOCUS trial, which is designed to assess the objective response rate in individuals with metastatic uveal melanoma whose disease is primarily concentrated in the liver. Furthermore, the company offers a separate version of HEPZATO as a medical device in Europe, marketed under the CHEMOSAT Hepatic Delivery System brand (or simply CHEMOSAT). This system empowers European medical centers to manage a diverse array of liver cancer conditions. Delcath Systems, Inc. was established in 1988, with its corporate headquarters situated in New York, New York.
Similar medical devices company
Sirtex Medical is a global healthcare company founded in 1997 with its U.S. headquarters in Woburn, Massachusetts. The company specializes in improving patient outcomes, offering products such as SIR-Spheres yttrium-90 microspheres, and maintains offices across the U.S., Australia, Germany, and Singapore.
Similar medical devices company
New World Medical, Inc. is a pioneering medical technology company founded in 1990 and headquartered in Rancho Cucamonga, California. The firm designs and manufactures ophthalmic devices aimed at improving the treatment of glaucoma.
Similar medical devices company
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
Similar medical devices company
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.
Similar medical devices company
Elios Vision, Inc. provides next-generation glaucoma treatment solutions designed to address glaucoma during routine cataract surgery. The available evidence does not explicitly state its headquarters country.
Medical - Devices
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
Similar medical devices company
iSTAR Medical is a venture-backed medical technology company headquartered in Wavre, Belgium, with an international office in the US. The company develops breakthrough eye care solutions and minimally-invasive implants featuring bio-indication to treat conditions like glaucoma.
Medical - Devices
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Glaukos Corporation and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Glaukos Corporationand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →